Austell Laboratories Overview
- Founded
-
2005
- Status
-
Private
- Employees
-
109
- Latest Deal Type
-
Mezzanine
- Latest Deal Amount
-
$9.9M
- Investors
-
1
Austell Laboratories General Information
Description
Operator of a pharmaceutical company catering to the South African market. The company is engaged in producing premium and generic medicines that are clinically proven to be safe and effective and are unique in their respective disease categories, enabling patients to avail themselves of improved healthcare drugs.
Contact Information
Website
www.austell.co.za
Formerly Known As
CAMOX Pharmaceuticals
Ownership Status
Privately Held (backing)
Financing Status
Private Debt Financed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Primary Office
- Post Office Box 1110
- Crown Mines, 2025
- South Africa
+27 011 000 0000
Austell Laboratories Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Mezzanine | 29-Aug-2014 | $9.9M | 00.00 | Completed | Generating Revenue |
Austell Laboratories Executive Team (5)
Austell Laboratories Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Austell Laboratories Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Vantage Capital | PE/Buyout | Minority | 000 0000 | 000000 0 |
Austell Laboratories Acquisitions (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 00000000 0000 | 31-Oct-2022 | 0000000000 | 000.00 | Pharmaceuticals |